Emergence of NOTCH2-NTRK1 After Osimertinib in a Patient With Lung Adenocarcinoma With Neuroendocrine Differentiation. Lin G, Liu Y, Li H, Chen S, et al. Clin Lung Cancer 2021;22:e157-e159.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lin G, Liu Y, Li H, Chen S, et al. Emergence of NOTCH2-NTRK1 After Osimertinib in a Patient With Lung Adenocarcinoma With Neuroendocrine Differentiation. Clin Lung Cancer 2021;22:e157-e159.
PMID: 33158763